|
Esteve-Pastor MA, Roldán V, Valdés M, Lip GY, Marín F. The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation. Expert Rev Cardiovasc Ther. 2016;14(2):177-87. doi: 10.1586/14779072.2016.1116941. Epub 2015 Dec 9. Review. PubMed PMID: 26559964.
AÑO: 2016
|
26559964
|
Esteve-Pastor MA, Núñez-Gil IJ, Marín F. The search for optimal anticoagulation therapy in ACS: The gap between clinical trials and current clinical guidelines. Thromb Haemost. 2015 Nov;114(5):872-4. doi: 10.1160/TH15-06-0512. PubMed PMID: 26271308.
AÑO: 2015; IF: 4.385
|
|
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27. English, Spanish. PubMed PMID: 28034682.
AÑO: 2017; IF: 5.166
|
|
Esteve-Pastor MA, García-Fernández A, Macías M, Sogorb F, Valdés M, Roldán V, Muñiz J, Badimon L, Roldán I, Bertomeu-Martínez V, Cequier Á, Lip GY, Anguita M, Marín F; FANTASIIA Investigators. Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients? Circ J. 2016 Sep 23;80(10):2102-8. doi: 10.1253/circj.CJ-16-0471. Epub 2016 Aug 24. PubMed PMID: 27557850.
AÑO: 2016; IF: 3.544
|
|
Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients. Thromb Haemost. 2017 Jun 27;117(7):1448-1454. doi: 10.1160/TH16-12-0961. Epub 2017 Mar 23. PubMed PMID: 28331926.
AÑO: 2017; IF: 6.681
|